Healthcare -
Biotechnology - NASDAQ - US
$ 3.345
1.36 %
$ 634 M
Market Cap
-7.78
P/E
ABUS - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative ABUS - Arbutus Biopharma Corporation
22.5 M
LAST VALUE
14.52%
2 YEAR CAGR
7.03%
5 YEAR CAGR
15.02%
10 YEAR CAGR